Marginal zone B cells: Virtues of innate-like antibody-producing lymphocytes

Nature Reviews Immunology

Volumn 13, Issue 2, 2013, Pages 118-132

  Cerutti, Andrea ^a,b,c   Cols, Montserrat ^b   Puga, Irene ^c  

^a Barcelona Biomedical Research Park   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; EFFECTOR CELL; HUMAN; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; B-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOID TISSUE; MUTATION; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84872946832     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3383     Document Type: Review

References (149)

1. Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
2. Cooper, M. D. & Alder, M. N. The evolution of adaptive immune systems. Cell 124, 815-822 (2006).
3. Bendelac, A., Bonneville, M. & Kearney, J. F. Autoreactivity by design: innate B and T lymphocytes. Nature Rev. Immunol. 1, 177-186 (2001).
4. Martin, F., Oliver, A. M. & Kearney, J. F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14, 617-629 (2001).
5. Martin, F. & Kearney, J. F. Marginal-zone B cells. Nature Rev. Immunol. 2, 323-335 (2002).
6. Treml, L. S. et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J. Immunol. 178, 7531-7539 (2007).
7. He, B. et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nature Immunol. 11, 836-845 (2010).
8. Pone, E. J. et al. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. Nature Commun. 3, 767 (2012).
9. Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nature Rev. Immunol. 5, 606-616 (2005).
10. Chen, Y. et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J. Immunol. 175, 8173-8180 (2005).
11. Kang, Y. S. et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125, 47-58 (2006).
12. Bergtold, A., Desai, D. D., Gavhane, A. & Clynes, R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23, 503-514 (2005).
13. Batista, F. D. & Harwood, N. E. The who, how and where of antigen presentation to B cells. Nature Rev. Immunol. 9, 15-27 (2009).
14. Balázs, M., Martin, F., Zhou, T. & Kearney, J. F. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341-352 (2002).
15. Colino, J., Shen, Y. & Snapper, C. M. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein-and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J. Exp. Med. 195, 1-13 (2002).
16. Steiniger, B., Barth, P. & Hellinger, A. The perifollicular and marginal zones of the human splenic white pulp: do fibroblasts guide lymphocyte immigration? Am. J. Pathol. 159, 501-512 (2001).
17. Steiniger, B., Timphus, E. & Barth, P. The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem. Cell Biol. 126, 641-648 (2006).
18. Puga, I. et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature Immunol. 13, 170-180 (2012).
19. Spencer, J., Finn, T., Pulford, K. A., Mason, D. Y. & Isaacson, P. G. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin. Exp. Immunol. 62, 607-612 (1985).
20. Tierens, A., Delabie, J., Michiels, L., Vandenberghe, P. & De Wolf-Peeters, C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 93, 226-234 (1999).
21. Dono, M. et al. Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J. Immunol. 164, 5596-5604 (2000).
22. Weill, J. C., Weller, S. & Reynaud, C. A. Human marginal zone B cells. Annu. Rev. Immunol. 27, 267-285 (2009).
23. Weller, S. et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104, 3647-3654 (2004).
24. Berkowska, M. A. et al. Human memory B cells originate from three distinct germinal center-dependent and-independent maturation pathways. Blood 118, 2150-2158 (2011).
25. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J. V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature Immunol. 1, 31-36 (2000).
26. MacLennan, I. C. et al. Extrafollicular antibody responses. Immunol. Rev. 194, 8-18 (2003).
27. Amlot, P. L. & Hayes, A. E. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections. Lancet 1, 1008-1011 (1985).
28. Kruetzmann, S. et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197, 939-945 (2003).
29. Castagnola, E. & Fioredda, F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur. J. Haematol. 71, 319-326 (2003).
30. Wasserstrom, H., Bussel, J., Lim, L. C. & Cunningham-Rundles, C. Memory B cells and pneumococcal antibody after splenectomy. J. Immunol. 181, 3684-3689 (2008).
31. Di Sabatino, A. et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastroenterol. 100, 1788-1795 (2005).
32. Traggiai, E. et al. Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation. PLoS ONE 5, e11262 (2010).
33. Carsetti, R. et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115, 412-417 (2005).
34. Hart, M. et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J. Immunol. 178, 8212-8220 (2007).
35. Weller, S. et al. IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-and TIRAP-but not UNC-93B-deficient patients. Blood 120, 4992-5001 (2012).
36. Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nature Rev. Immunol. 9, 767-777 (2009).
37. Szomolanyi-Tsuda, E. & Welsh, R. M. T-cell-independent antiviral antibody responses. Curr. Opin. Immunol. 10, 431-435 (1998).
38. Gatto, D., Ruedl, C., Odermatt, B. & Bachmann, M. F. Rapid response of marginal zone B cells to viral particles. J. Immunol. 173, 4308-4316 (2004).
39. Galili, U., Rachmilewitz, E. A., Peleg, A. & Flechner, I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 160, 1519-1531 (1984).
40. Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159 (1999).
41. Macpherson, A. J. & Harris, N. L. Interactions between commensal intestinal bacteria and the immune system. Nature Rev. Immunol. 4, 478-485 (2004).
42. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
43. Wei, B. et al. Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur. J. Immunol. 38, 3411-3425 (2008).
44. Clarke, T. B. et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Med. 16, 228-231 (2010).
45. Lamouse-Smith, E. S., Tzeng, A. & Starnbach, M. N. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS ONE 6, e27662 (2011).
46. Bos, N. A. et al. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur. J. Immunol. 19, 2335-2339 (1989).
47. Butler, J. E. et al. Antibody repertoire development in fetal and neonatal piglets. II. Characterization of heavy chain complementarity- determining region 3 diversity in the developing fetus. J. Immunol. 165, 6999-7010 (2000).
48. Kool, J. et al. Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats. J. Histochem. Cytochem. 42, 1435-1441 (1994).
49. Krueger, J. M. et al. Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination. J. Biol. Chem. 259, 12659-12662 (1984).
50. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med. 12, 1365-1371 (2006).
51. Haas, A. et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 60, 1506-1519 (2011).
52. Chung, J. B., Silverman, M. & Monroe, J. G. Transitional B cells: step by step towards immune competence. Trends Immunol. 24, 343-349 (2003).
53. Mackay, F. & Schneider, P. Cracking the BAFF code. Nature Rev. Immunol. 9, 491-502 (2009).
54. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12, 39-49 (2000).
55. Cariappa, A. et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14, 603-615 (2001).
56. Wen, L. et al. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 23, 297-308 (2005).
57. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nature Immunol. 3, 443-450 (2002).
58. Hampel, F. et al. CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling. Blood 118, 6321-6331 (2011).
59. Scheeren, F. A. et al. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J. Exp. Med. 205, 2033-2042 (2008).
60. Capolunghi, F. et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180, 800-808 (2008).
61. Tsuiji, M. et al. A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 203, 393-400 (2006).
62. Isnardi, I. et al. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29, 746-757 (2008).
63. Cinamon, G. et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nature Immunol. 5, 713-720 (2004).
64. Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W. Jr & Cyster, J. G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nature Immunol. 9, 54-62 (2008).
65. Lu, T. T. & Cyster, J. G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297, 409-412 (2002).
66. Fukui, Y. et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 412, 826-831 (2001).
67. Croker, B. A. et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168, 3376-3386 (2002).
68. Rubtsov, A. et al. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 23, 527-538 (2005).
69. Karlsson, M. C. et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198, 333-340 (2003).
70. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. & Fearon, D. T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350 (1996).
71. Test, S. T., Mitsuyoshi, J., Connolly, C. C. & Lucas, A. H. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69, 3031-3040 (2001).
72. Song, H. & Cerny, J. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J. Exp. Med. 198, 1923-1935 (2003).
73. Chappell, C. P., Draves, K. E., Giltiay, N. V. & Clark, E. A. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J. Exp. Med. 209, 1825-1840 (2012).
74. Weller, S. et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl Acad. Sci. USA 98, 1166-1170 (2001).
75. Weller, S. et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J. Exp. Med. 205, 1331-1342 (2008).
76. Genestier, L. et al. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J. Immunol. 178, 7779-7786 (2007).
77. Rubtsov, A. V. et al. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J. Immunol. 180, 3882-3888 (2008).
78. Rawlings, D. J., Schwartz, M. A., Jackson, S. W. & Meyer-Bahlburg, A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nature Rev. Immunol. 12, 282-294 (2012).
79. Belperron, A. A., Dailey, C. M. & Bockenstedt, L. K. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 174, 5681-5686 (2005).
80. Haas, K. M., Poe, J. C. & Tedder, T. F. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J. Immunol. 183, 3661-3671 (2009).
81. Garcia de Vinuesa, C., O'Leary, P., Sze, D. M., Toellner, K. M. & MacLennan, I. C. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol. 29, 1314-1323 (1999).
82. Timens, W., Boes, A. & Poppema, S. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur. J. Immunol. 19, 2163-2166 (1989).
83. Tangye, S. G., Liu, Y. J., Aversa, G., Phillips, J. H. & de Vries, J. E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188, 1691-1703 (1998).
84. Dunn-Walters, D. K., Isaacson, P. G. & Spencer, J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182, 559-566 (1995).
85. Klein, U., Rajewsky, K. & Kuppers, R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188, 1679-1689 (1998).
86. Seifert, M. & Kuppers, R. Molecular footprints of a germinal center derivation of human IgM+(IgD+) CD27+ B cells and the dynamics of memory B cell generation. J. Exp. Med. 206, 2659-2669 (2009).
87. Tangye, S. G. & Good, K. L. Human IgM+CD27+ B cells: memory B cells or "memory" B cells? J. Immunol. 179, 13-19 (2007).
88. Kuraoka, M. et al. Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J. Immunol. 183, 3237-3248 (2009).
89. Roll, P., Palanichamy, A., Kneitz, C., Dorner, T. & Tony, H. P. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum. 54, 2377-2386 (2006).
90. Carey, J. B., Moffatt-Blue, C. S., Watson, L. C., Gavin, A. L. & Feeney, A. J. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp.Med. 205, 2043-2052 (2008).
91. Swanson, C. L. et al. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207, 1485-1500 (2010).
92. Do, R. K. et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192, 953-964 (2000).
93. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. & Kearney, J. F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27, 2366-2374 (1997).
94. Mond, J. J., Lees, A. & Snapper, C. M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13, 655-692 (1995).
95. Garcia De Vinuesa, C. et al. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29, 3712-3721 (1999).
96. Litinskiy, M. B. et al. Antigen presenting cells induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nature Immunol. 3, 822-829 (2002).
97. Pack, M. et al. DEC-205/CD205+ dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp. Immunology 123, 438-446 (2008).
98. Ogembo, J. G. et al. SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen. J. Immunol. 188, 4496-4505 (2012).
99. Cols, M. et al. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J. Immunol. 188, 6071-6083 (2012).
100. Xu, W. et al. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nature Immunol. 8, 294-303 (2007).
101. He, B., Qiao, X. & Cerutti, A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173, 4479-4491 (2004).
102. Groom, J. R. et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 204, 1959-1971 (2007).
103. Castigli, E. et al. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J. Allergy Clin. Immunol. 120, 885-891 (2007).
104. Brodeur, S. R. et al. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18, 837-848 (2003).
105. Li, S. et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 110, 3926-3935 (2007).
106. Leadbetter, E. A. et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Natl Acad. Sci. USA 105, 8339-8344 (2008).
107. Snapper, C. M. Mechanisms underlying in vivo polysaccharide-specific immunoglobulin responses to intact extracellular bacteria. Ann. NY Acad. Sci. 1253, 92-101 (2012).
108. Cunningham, A. F. et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J. Immunol. 178, 6200-6207 (2007).
109. Cobb, B. A., Wang, Q., Tzianabos, A. O. & Kasper, D. L. Polysaccharide processing and presentation by the MHCII pathway. Cell 117, 677-687 (2004).
110. Oliver, A. M., Martin, F. & Kearney, J. F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162, 7198-7207 (1999).
111. Attanavanich, K. & Kearney, J. F. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172, 803-811 (2004).
112. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011).
113. Idoyaga, J., Suda, N., Suda, K., Park, C. G. & Steinman, R. M. Antibody to Langerin/CD207 localizes large numbers of CD8α+ dendritic cells to the marginal zone of mouse spleen. Proc. Natl Acad. Sci. USA 106, 1524-1529 (2009).
114. Schmitt, N. et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31, 158-169 (2009).
115. Bentebibel, S. E., Schmitt, N., Banchereau, J. & Ueno, H. Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc. Natl Acad. Sci. USA 108, E488-E497 (2011).
116. Barral, P. et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl Acad. Sci. USA 105, 8345-8350 (2008).
117. Bialecki, E. et al. Role of marginal zone B lymphocytes in invariant NKT cell activation. J. Immunol. 182, 6105-6113 (2009).
118. De Santo, C. et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nature Immunol. 11, 1039-1046 (2010).
119. Hargreaves, D. C. et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194, 45-56 (2001).
120. Ellyard, J. I., Avery, D. T., Mackay, C. R. & Tangye, S. G. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Eur. J. Immunol. 35, 699-708 (2005).
121. Avery, D. T. et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286-297 (2003).
122. He, B. et al. Intestinal bacteria trigger T cell-independent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007).
123. Lindh, E. et al. AIRE regulates T-cell-independent B-cell responses through BAFF. Proc. Natl Acad. Sci. USA 105, 18466-18471 (2008).
124. Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225-234 (2003).
125. Xu, W. et al. Macrophages induce differentiation of plasma cells through CXCL10/IP-10. J. Exp. Med. 209, 1813-1823 (2012).
126. Hendricks, J. et al. Class-switched marginal zone B cells in spleen have relatively low numbers of somatic mutations. Mol. Immunol. 48, 874-882 (2011).
127. Scapini, P. et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197, 297-302 (2003).
128. Crepaldi, L. et al. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J. Immunol. 167, 2312-2322 (2001).
129. Rauch, P. J. et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597-601 (2012).
130. Chu, V. T. et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nature Immunol. 12, 151-159 (2011).
131. Bernasconi, N. L., Traggiai, E. & Lanzavecchia, A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202 (2002).
132. Lande, R. et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).
133. He, B. et al. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176, 3931-3941 (2006).
134. Castigli, E. et al. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201, 35-39 (2005).
135. Kaminski, D. A. & Stavnezer, J. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J. Immunol. 177, 6025-6029 (2006).
136. Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 (2001).
137. Barral, P. et al. CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nature Immunol. 11, 303-312 (2010).
138. Tarkowski, A. et al. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 144, 3770-3778 (1990).
139. Carson, P. J., Schut, R. L., Simpson, M. L., O'Brien, J. & Janoff, E. N. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J. Infect. Dis. 172, 340-345 (1995).
140. Dammers, P. M., de Boer, N. K., Deenen, G. J., Nieuwenhuis, P. & Kroese, F. G. The origin of marginal zone B cells in the rat. Eur. J. Immunol. 29, 1522-1531 (1999).
141. Toellner, K. M. et al. Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J. Exp. Med. 195, 383-389 (2002).
142. Herlands, R. A., Christensen, S. R., Sweet, R. A., Hershberg, U. & Shlomchik, M. J. T cell-independent and Toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29, 249-260 (2008).
143. Lanning, D. K., Rhee, K. J. & Knight, K. L. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol. 26, 419-425 (2005).
144. Mao, C. et al. T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity 20, 133-144 (2004).
145. Aranburu, A. et al. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J. Immunol. 185, 7293-7301 (2010).
146. van de Pavert, S. A. & Mebius, R. E. New insights into the development of lymphoid tissues. Nature Rev. Immunol. 10, 664-674 (2010).
147. Zindl, C. L. et al. The lymphotoxin LTα1β2 controls postnatal and adult spleen marginal sinus vascular structure and function. Immunity 30, 408-420 (2009).
148. Mueller, S. N. & Germain, R. N. Stromal cell contributions to the homeostasis and functionality of the immune system. Nature Rev. Immunol. 9, 618-629 (2009).
149. Schneider, K. et al. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3, 67-76 (2008).